Phase 1 study of MDL-001
Latest Information Update: 28 Jan 2025
Price :
$35 *
At a glance
- Drugs MDL 001 (Primary)
- Indications COVID 2019 infections; Influenza A virus H1N1 subtype
- Focus Adverse reactions
- 28 Jan 2025 New trial record
- 21 Jan 2025 Results presented in a Model Medicines Media Release.